A third dose of COVID-19 vaccine incr... - Lung Conditions C...

Lung Conditions Community Forum

56,244 members66,867 posts

A third dose of COVID-19 vaccine increased antibody levels in organ transplant recipients

2greys profile image
3 Replies

The antibody response after 2 doses of an mRNA vaccine against SARS-CoV-2 is excellent in the general population, but the response is different in recipients of solid organ transplants. For example, we have found markedly attenuated antibody responses in transplant recipients after 2 doses of an mRNA vaccine against SARS-CoV-2 (2). In addition, reports of COVID-19 breakthrough infections in vaccinated transplant recipients have prompted interest in administering additional doses of vaccine.

To describe antibody responses and vaccine reactions in recipients of solid organ transplants who had a suboptimal response to standard vaccination and subsequently received a third dose of vaccine between 20 March 2021 and 10 May 2021.

acpjournals.org/doi/10.7326...

Written by
2greys profile image
2greys
To view profiles and participate in discussions please or .
Read more about...
3 Replies
hypercat54 profile image
hypercat54

I learn so much from your links so many thanks for posting them. I (and I think most of us) always read your posts. Your links are always first class and we know they are properly researched. . x

MELNEL profile image
MELNEL

👍 interesting 🤓

Oshgosh profile image
Oshgosh

Thank you, I’m immuno suppressed, so this info about it third vaccination is encouraging .

Not what you're looking for?

You may also like...

Pfizer-BioNTech vaccine recipients have lower antibody levels targeting the Delta variant

Levels of antibodies in the blood of vaccinated people that are able to recognise and fight the new...
2greys profile image

Phase 2/3 trial of Oxford COVID-19 vaccine in healthy older adults finds it is safe and provokes immune response.

The UK's vaccine against SARS-CoV-2 shows similar safety and immunogenicity results in healthy...
2greys profile image

Investigational COVID-19 vaccine well-tolerated and generates immune response in older adults.

A Phase 1 trial of an investigational mRNA vaccine to prevent SARS-CoV-2 infection has shown that...
2greys profile image

‘Universal Covid vaccine’ could be developed within a year, Second-generation jab may work against all variants of coronavirus.

Scancell Holdings plc, (AIM:SCLP), the developer of novel immunotherapies is pleased to announce...
2greys profile image

Immunological memory after SARS-CoV-2 infection recovery. *The welcome news we have been waiting for*

Until now, it was unclear whether a survived SARS-CoV-2 infection or COVID-19 leads to a persistent...
2greys profile image

Moderation team

See all
moderator_AandLUK profile image
moderator_AandLUKAdministrator
AsthmaandLung profile image
AsthmaandLungAdministrator
Claire_ALUK profile image
Claire_ALUKAdministrator

Content on HealthUnlocked does not replace the relationship between you and doctors or other healthcare professionals nor the advice you receive from them.

Never delay seeking advice or dialling emergency services because of something that you have read on HealthUnlocked.